Accelerate Diagnostics, Inc. (AXDXQ)

OTCMKTS · Delayed Price · Currency is USD

0.000001

0.00 (0.00%)

Inactive · Last trade price on Aug 20, 2025

Accelerate Diagnostics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	11.7	11.7	12.06	12.75	11.78	11.17
Revenue Growth	-2.99%	-2.99%	-5.43%	8.23%	5.53%	20.09%
Gross Profit	2.7	2.7	2.55	3.3	-0.38	4.46
Operating Income	-35.31	-35.31	-54.03	-62.81	-71.56	-63.3
Net Income	-50.05	-50.05	-61.62	-62.49	-77.7	-78.21
Earnings Per Share	-2.15	-2.15	-4.94	-7.61	-12.59	-14.00
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	FY TTM	FY NaN	FY NaN	FY NaN	FY NaN
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Accelerate Pheno	11.93	12.6	11.63	11.03	9.13
Other	0.13	0.15	0.15	0.14	0.17

Cash & Debt

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Investments	16.3	16.3	13.22	45.56	63.62	68.27
Total Debt	66.58	66.58	39.22	77.54	111.11	149.98
Net Cash (Debt)	-50.28	-50.28	-26	-31.98	-47.5	-81.71
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-2.16	-2.16	-2.08	-3.89	-7.69	-14.59

Cash Flow & CapEx

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Cash Flow	-24.19	-24.19	-40.2	-48.73	-47.32	-50.39
Capital Expenditures	-0.51	-0.51	-1.04	-0.55	-0.6	-1.36
Free Cash Flow	-24.7	-24.7	-41.23	-49.28	-47.93	-51.76
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Gross Margin	23.11%	23.11%	21.15%	25.90%	-3.23%	39.94%
Operating Margin	-301.85%	-301.85%	-448.03%	-492.51%	-607.37%	-566.95%
Pretax Margin	-428.37%	-428.37%	-503.92%	-490.67%	-659.12%	-700.43%
Profit Margin	-427.81%	-427.81%	-510.97%	-490.06%	-659.50%	-700.47%
FCF Margin	-211.17%	-211.17%	-341.91%	-386.47%	-406.77%	-463.56%

Valuation

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '26 Aug 16, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
PS Ratio	0	2.57	4.73	5.49	30.87	38.72